Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma
Clinical trial NCT01241708 · COMPLETED
Trial details
- NCT number
- NCT01241708
- Sponsor
- Hackensack Meridian Health
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-08
- Primary completion
- 2023-07-15
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.